Vermont Primary Care Provider Perspectives on Psychedelics — A Cross-Sectional Study
Journal of Psychoactive Drugs March 5, 2025 Josephine Yalovitser, Jonah Levine, Cole Zweber et al. 1 citation
The medical utility of psychedelics has been the subject of significant scientific interest in recent years. While most of these substances remain Schedule I under the Controlled Substances Act, advancements in research have led states to consider expanding legal access, impacting primary care, where patients often seek mental health support and treatment. In July 2023 we conducted a...